Loading…
Based on limited metadata, Bella Rose Labs, a dietary supplement manufacturer, received an FDA Warning Letter on November 22, 2019. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The warning falls under FDA's dietary supplement regulatory authority, though the specific issuing office and violation count are not documented in this metadata. To understand the particular compliance issues cited, the complete Warning Letter text would need to be reviewed.